伟思医疗
(688580)
| 流通市值：31.49亿 | | | 总市值：31.49亿 |
| 流通股本：6862.39万 | | | 总股本：6862.39万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,114,688,351.56 | 1,154,989,792.54 | 1,133,178,524 | 1,145,725,857.26 |
| 应收票据及应收账款 | 36,730,380.92 | 36,620,133.9 | 31,168,040.73 | 27,047,673.96 |
| 应收账款 | 36,730,380.92 | 36,620,133.9 | 31,168,040.73 | 27,047,673.96 |
| 预付款项 | 7,703,743.92 | 5,798,482.19 | 4,168,260.89 | 4,584,862.06 |
| 其他应收款合计 | 6,105,919.66 | 4,897,136.65 | 3,536,394.66 | 5,679,908.44 |
| 存货 | 41,273,617.42 | 39,916,747.46 | 41,997,520.06 | 41,910,088.07 |
| 其他流动资产 | 15,730,041.22 | 12,605,716.69 | 11,242,196.82 | 8,442,093.15 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,222,232,054.7 | 1,254,828,009.43 | 1,225,290,937.16 | 1,233,390,482.94 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 22,035,950.26 | 22,035,950.26 | 23,000,000 | 23,000,000 |
| 固定资产 | 93,720,938.43 | 96,076,595.89 | 95,780,224.51 | 96,345,997.34 |
| 在建工程 | 242,412,758.15 | 224,859,149.68 | 198,351,426.25 | 164,650,414.66 |
| 使用权资产 | 299,073.35 | 596,480.39 | 893,887.43 | 1,191,294.47 |
| 无形资产 | 107,680,373.02 | 109,082,075.12 | 100,082,401.36 | 101,573,507.58 |
| 开发支出 | 14,915,963.56 | 11,492,200.66 | 12,864,963.25 | 9,146,400.63 |
| 商誉 | 69,306,067.79 | 69,306,067.79 | 69,306,067.79 | 69,306,067.79 |
| 长期待摊费用 | 2,618,263.66 | 1,249,177.01 | 1,567,135.63 | 1,833,459.82 |
| 递延所得税资产 | 17,837,120.98 | 15,103,129.91 | 10,593,225.33 | 9,973,529.37 |
| 其他非流动资产 | 3,465,867.14 | 1,395,205 | 3,176,980.79 | 2,862,560.22 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 574,292,376.34 | 551,196,031.71 | 515,616,312.34 | 479,883,231.88 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,796,524,431.04 | 1,806,024,041.14 | 1,740,907,249.5 | 1,713,273,714.82 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 14,012,115.94 | 17,956,791.32 | 16,821,482.09 | 23,554,817.03 |
| 应付账款 | 14,012,115.94 | 17,956,791.32 | 16,821,482.09 | 23,554,817.03 |
| 预收款项 | 1,284,437.86 | 1,192,476.71 | 2,105,315.71 | 2,730,980.91 |
| 合同负债 | 2,871,722.07 | 5,082,723.52 | 4,158,477.02 | 7,530,589.75 |
| 应付职工薪酬 | 9,904,440.03 | 24,198,485.23 | 10,148,066.28 | 9,848,074.78 |
| 应交税费 | 16,768,117.36 | 19,630,474.48 | 15,941,668.29 | 18,764,842.35 |
| 其他应付款合计 | 71,151,091.26 | 83,533,836.27 | 75,334,054.88 | 72,238,079.9 |
| 一年内到期的非流动负债 | - | - | - | 1,238,750.87 |
| 其他流动负债 | 35,849 | 88,215.93 | 60,398.23 | 51,861.9 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 116,027,773.52 | 151,683,003.46 | 124,569,462.5 | 135,957,997.49 |
| 非流动负债: | | | | |
| 长期应付款 | 27,425,703.05 | 27,103,844.9 | 26,789,341.64 | 26,484,491.84 |
| 递延收益 | 3,741,285.94 | - | 142,891.17 | 255,936.49 |
| 递延所得税负债 | 465,260.82 | 481,973.83 | 498,861.51 | 515,770.77 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 31,632,249.81 | 27,585,818.73 | 27,431,094.32 | 27,256,199.1 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 147,660,023.33 | 179,268,822.19 | 152,000,556.82 | 163,214,196.59 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 68,623,867 | 68,623,867 | 68,623,867 | 68,623,867 |
| 资本公积 | 1,118,902,977.05 | 1,111,844,639.51 | 1,102,155,808.31 | 1,094,432,356.96 |
| 减:库存股 | 33,152,505.72 | 26,450,203.61 | 20,032,372.63 | 20,032,372.63 |
| 盈余公积 | 34,311,933.5 | 34,311,933.5 | 34,311,933.5 | 34,311,933.5 |
| 未分配利润 | 460,178,135.88 | 438,424,982.55 | 403,847,456.5 | 372,723,733.4 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,648,864,407.71 | 1,626,755,218.95 | 1,588,906,692.68 | 1,550,059,518.23 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,648,864,407.71 | 1,626,755,218.95 | 1,588,906,692.68 | 1,550,059,518.23 |
| 负债和股东权益合计 | 1,796,524,431.04 | 1,806,024,041.14 | 1,740,907,249.5 | 1,713,273,714.82 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-26 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |